XML 72 R55.htm IDEA: XBRL DOCUMENT v3.23.1

Revenue - Jansen Agreement (Details) - USD ($) $ in Thousands	1 Months Ended			12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020	May 31, 2020	Dec. 31, 2022	Dec. 31, 2021
Research and license agreement
Revenue
Development milestones payment received	$ 1,000
Janssen Biotech Inc
Revenue
Deferred revenue at beginning of period				$ (1,527)	$ (6,176)
Deferral of revenue				(35,000)
Recognized during the period				1,490	4,354
Foreign currency translation difference				37	295
Deferred revenue at end of period		$ (6,176)		$ (35,000)	$ (1,527)
Development milestones payment received		$ 1,000
Janssen Biotech Inc | Research and license agreement
Revenue
Non-refundable upfront payment received			$ 8,000
Term of agreement			2 years
Years of sale for royalties payable				10 years
Deferred revenue at end of period				$ 0

X

- Definition

The amount of an entity’s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2022-03-24
-Paragraph 105
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_105&doctype=Standard
-URIDate 2022-03-24

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2022-03-24
-Paragraph 116
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_116_a&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_ContractLiabilities
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The decrease in contract liabilities resulting from the performance obligation being satisfied. [Refer: Contract liabilities; Performance obligations [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 15
-IssueDate 2022-03-24
-Paragraph 118
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_118_e&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_DecreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The increase (decrease) in contract liabilities resulting from cumulative catch-up adjustments to revenue. [Refer: Contract liabilities; Revenue from contracts with customers]

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 15
-IssueDate 2022-03-24
-Paragraph 118
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_118_b&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_IncreaseDecreaseThroughCumulativeCatchupAdjustmentsToRevenueContractLiabilities
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The increase (decrease) in contract liabilities resulting from foreign currency translation difference.

+ References

No definition available.

+ Details

Name:	lvtx_IncreaseDecreaseThroughForeignCurrencyTranslationDifferenceContractLiabilities
Namespace Prefix:	lvtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Development milestones payment received under research and license agreement.

+ References

No definition available.

+ Details

Name:	lvtx_ResearchAndLicenseAgreementDevelopmentMilestonesPaymentReceived
Namespace Prefix:	lvtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Non-refundable upfront payment received under research and license agreement.

+ References

No definition available.

+ Details

Name:	lvtx_ResearchAndLicenseAgreementNonRefundableUpfrontPaymentReceived
Namespace Prefix:	lvtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Years of sale for royalties payable under research and license agreement.

+ References

No definition available.

+ Details

Name:	lvtx_ResearchAndLicenseAgreementRoyaltiesPayableYearsOfSale
Namespace Prefix:	lvtx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Term of agreement over which upfront payment received are recognized on a straight-line basis.

+ References

No definition available.

+ Details

Name:	lvtx_TermOfResearchAndLicenseAgreement
Namespace Prefix:	lvtx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	lvtx_IfrsCollaborativeArrangementAndArrangementOtherThanCollaborativeAxis=lvtx_ResearchAndLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CounterpartiesAxis=lvtx_JanssenBiotechincMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: